Investment Thesis
Agilent demonstrates strong fundamental health with excellent profitability (20.7% operating margin, 17.7% net margin) and robust free cash flow generation ($376M, 10.3% FCF margin). Conservative capital structure and strong liquidity provide financial flexibility, but decelerating earnings growth (1.1% YoY) relative to revenue growth (6.7%) suggests potential margin compression and mature growth phase.
Strengths
- Exceptional free cash flow generation with 10.3% FCF margin enables dividends and debt reduction
- Strong balance sheet with conservative 0.43x debt/equity and 15x interest coverage providing financial flexibility
- Healthy profitability margins (20.7% operating, 17.7% net) indicating pricing power and operational efficiency in essential analytical instrumentation
- Solid liquidity position with 2.10x current ratio and $1.8B cash reserves
Risks
- Significant earnings growth deceleration (1.1% net income growth vs 6.7% revenue growth) signals margin compression or operational challenges
- Low return on equity at 9.0% suggests suboptimal capital deployment and limited value creation per dollar invested
- Mature market exposure may limit future revenue growth acceleration and earnings expansion
Key Metrics to Watch
- Gross margin trend - critical to understand if compression stems from pricing pressure or rising input costs
- Operating cash flow sustainability and year-over-year growth trajectory
- Return on equity improvement initiatives and asset turnover efficiency
Financial Metrics
Revenue
3.6B
Net Income
644.0M
EPS (Diluted)
$2.27
Free Cash Flow
376.0M
Total Assets
13.1B
Cash
1.8B
Profitability Ratios
Gross Margin
N/A
Operating Margin
20.7%
Net Margin
17.7%
ROE
9.0%
ROA
4.9%
FCF Margin
10.3%
Balance Sheet & Liquidity
Current Ratio
2.10x
Quick Ratio
1.62x
Debt/Equity
0.43x
Debt/Assets
45.5%
Interest Coverage
15.04x
Long-term Debt
3.1B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-06-02T07:32:42.238340 |
Data as of: 2026-04-30 |
Powered by Claude AI